Epicardial Pulsed Field Ablation of Ganglionated Plexi: Computational and Pre-Clinical Evaluation of a Bipolar Sub-Xiphoid Catheter for the Treatment of Atrial Fibrillation.

atrial fibrillation epicardial ganglionated plexi pulsed field ablation subxiphoid

Journal

Bioengineering (Basel, Switzerland)
ISSN: 2306-5354
Titre abrégé: Bioengineering (Basel)
Pays: Switzerland
ID NLM: 101676056

Informations de publication

Date de publication:
24 Dec 2023
Historique:
received: 15 11 2023
revised: 13 12 2023
accepted: 22 12 2023
medline: 22 1 2024
pubmed: 22 1 2024
entrez: 22 1 2024
Statut: epublish

Résumé

Epicardial pulsed field ablation (PFA) of ganglionated plexi (GPs) is being explored as a potential treatment for atrial fibrillation. Initial work using open-chest access with a monopolar ablation device has been completed. This study describes the early development work for a device that can be used with subxiphoid access and deliver bipolar ablation pulses. Electric field computational models have been used for the initial guidance on pulse parameters. An in vivo assessment of these ablation parameters has been performed in an open-chest canine study, while subxiphoid access and navigation of the device has been demonstrated in a porcine model. Results from this acute study have demonstrated the promising potential of this approach.

Identifiants

pubmed: 38247895
pii: bioengineering11010018
doi: 10.3390/bioengineering11010018
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Barry O'Brien (B)

AtriAN Medical Ltd., Unit 204, Business Innovation Centre, Upper Newcastle, H91 W60E Galway, Ireland.

John Reilly (J)

AtriAN Medical Ltd., Unit 204, Business Innovation Centre, Upper Newcastle, H91 W60E Galway, Ireland.

Ken Coffey (K)

AtriAN Medical Ltd., Unit 204, Business Innovation Centre, Upper Newcastle, H91 W60E Galway, Ireland.

Ana González-Suárez (A)

Translational Medical Device Laboratory, School of Medicine, University of Galway, H91 YR71 Galway, Ireland.
Valencian International University, Valencia, Spain.

Piotr Buchta (P)

3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
Silesian Center for Heart Diseases, 41-800 Zabrze, Poland.
Center for Cardiovascular Research and Development, American Heart of Poland, Kostkowice, Poland.

Piotr P Buszman (PP)

Center for Cardiovascular Research and Development, American Heart of Poland, Kostkowice, Poland.
Andrzej Frycz Modrzewski Kraków University, 30-705 Kraków, Poland.

Karolina Lukasik (K)

Center for Cardiovascular Research and Development, American Heart of Poland, Kostkowice, Poland.

Jason Tri (J)

Mayo Clinic, Rochester, MN 55905, USA.

Martin van Zyl (M)

Royal Jubilee Hospital, University of British Columbia, Victoria, BC, Canada.

Samuel Asirvatham (S)

Mayo Clinic, Rochester, MN 55905, USA.

Classifications MeSH